Signant Health Brings eConsent Solution to China

September 16, 2019

Applied Clinical Trials

Signant Health has been selected to provide electronic informed consent for a significant neuroscience study by the Shanghai Mental Health Center. This investigator-led Schizophrenia trial will enroll hundreds of patienta and implement Signant’s TrialConsent solution in China.

To learn more, click here.

Related Content:

News